This client update highlights key considerations for the preparation of your 2024 annual report on Form 20-F. As in previous years, we discuss both disclosure developments and continued a...
This client update highlights key considerations for the preparation of your 2023 annual report on Form 20-F. As in previous years, we discuss both disclosure developments and continued a...
After the SEC failed to remedy the deficiencies in the rule that the court had identified in its recent opinion, the Fifth Circuit vacated the share repurchase rule that the SEC adopted i...
Buried in a defense spending bill that clocks in at over 2,000 pages is an amendment to Section 16 of the Exchange Act that would extend its application to foreign private issuers, adding...
Webinar
1.0 CA - General; NY - Professional Practice / Practice Management
Davis Polk recently hosted its second in its current series of webinars focused on legal considerations for life sciences and healthcare companies. In this second installment, Davis Polk ...
Webinar
1.0 NY - Professional Practice / Practice Management
Davis Polk is pleased to host a series of webinars over the coming months focused on legal considerations for life sciences companies. In this first installment, senior members of the Dav...
This client update highlights some considerations for the preparation of your 2022 annual report on Form 20-F. As in previous years, we discuss both disclosure developments and continued ...
On June 23rd, the staff of the SEC’s Division of Corporation Finance issued new Disclosure Guidance Topic No. 9A reflecting the staff’s current views regarding disclosure that compani...
With the end of the first quarter upon us, we’ve put together some practical tips and recommendations for those working on public company first quarter reporting in light of the impact ...